Abstract
Malignancy accounts for 40%–60% of pericardial effusions. Two individuals with malignant pericardial effusions secondary to lung cancer, managed with the help of a percutaneous balloon pericardial window (PBPW), are discussed in this report. Clinical benefits in terms of reduction of breathlessness and improved diastolic function of the heart were documented in both. There were no procedure-related complications. The PBPW provides quick relief, appears diagnostically superior to an invasive technique and has a low rate of recurrence and complications.
This is a preview of subscription content, log in via an institution to check access.
References
Alcan KE, Zabetakis PM, Marino ND, et al (1982) Management of acute pericardial tamponade by subxiphoid pericardiotomy. JAMA 247:1143–1148
Appelqvist P, Maamies T, Grohn P (1982) Emergency pericardiotomy as primary diagnostic and therapeutic procedure in malignant pericardial tamponade; report of three cases and review of the literature. J Surg Oncol 21:18–22
Biran S, Hochman A, Levij IS, Stern S (1969) Clinical diagnosis of secondary tumours of the heart and pericardium. Dis Chest 55:208–208
Bisel HF, Wroblewski F, LaDue JS (1953) Incidence and clinical manifestations of cardiac metastases. JAMA 153:712–715
Guberman BA, Fowler NO, Engel PJ, Mosche G, Allen JM (1981) Cardiac tamponade in medical patients. Circulation 64:633–640
Himelman RB, Kircher B, Rockey DC, Schiller NB (1988) Inferior vena cava plethora with blunted respiratory response: a sensitive echocardiographic sign of cardiac tamponade. J Am Coll Cardiol 12:1470–1477
Krikorian JG, Hancock EW (1978) Pericardiocentesis. Am J Med 65:808–814
Lokich JJ (1973) The management of malignant pericardial effusions. JAMA 224:1401–1440
Markiewicz W, Borovik R, Ecker S (1986) Cardiac tamponade in medical patients: treatment and prognosis in the echocardiographic era. Am Heart J 111:1138–1142
Palacious IF, Tuzcu EM, Ziskind AA, Younger J, Block PC (1991) PBPW for patients with malignant pericardial effusion and tamponade. Cathet Cardiovasc Diagn 22:244–249
Piehler JM, Pluth JR, Schaff HV, et al (1985) Surgical management of effusive pericardial disease. J Thorac Cardiovasc Surg 90:506–516
Santos GH, Frater RWM (1977) The subxiphoid approach in the treatment of pericardial effusion. Ann Thorac Surg 23:467–470
Shepherd FA, Morgan C, Evans WK, et al (1987) Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 60:1161–1166
Terry LN, Kilgerman MM (1970) Pericardial and myocardial in volvement by lymphomas and leukemias: the role of radiotherapy. Cancer 25:1003–1008
Theologides A (1978) Neoplastic cardiac tamponade. Semin Oncol 51:181–192
Thurber DL, Edwards JE, Achor RW (1962) Secondary malignant tumours of the pericardium. Circulation 26:228–241
Wong B, Murphy J, Change CJ, et al (1979) The risk of pericardiocentesis. Am J Cardiol 44:1110–1114
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, A., Kamble, R., Kumar, L. et al. Palliative treatment of malignant pericardial effusion: Report of two cases and a review of the literature. Support Care Cancer 4, 317–319 (1996). https://doi.org/10.1007/BF01358888
Issue Date:
DOI: https://doi.org/10.1007/BF01358888